AU5315900A - LTiGTstreptococcus pneumoniaeLT/iGT vaccine strain and uses thereof - Google Patents

LTiGTstreptococcus pneumoniaeLT/iGT vaccine strain and uses thereof

Info

Publication number
AU5315900A
AU5315900A AU53159/00A AU5315900A AU5315900A AU 5315900 A AU5315900 A AU 5315900A AU 53159/00 A AU53159/00 A AU 53159/00A AU 5315900 A AU5315900 A AU 5315900A AU 5315900 A AU5315900 A AU 5315900A
Authority
AU
Australia
Prior art keywords
pneumoniaelt
ltigtstreptococcus
igt
vaccine strain
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53159/00A
Inventor
Ashalla Magee
Janet Yother
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of AU5315900A publication Critical patent/AU5315900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU53159/00A 1999-06-01 2000-06-01 LTiGTstreptococcus pneumoniaeLT/iGT vaccine strain and uses thereof Abandoned AU5315900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13692799P 1999-06-01 1999-06-01
US60136927 1999-06-01
PCT/US2000/015231 WO2000072803A2 (en) 1999-06-01 2000-06-01 Streptococcus pneumoniae vaccine strain and uses thereof

Publications (1)

Publication Number Publication Date
AU5315900A true AU5315900A (en) 2000-12-18

Family

ID=22475046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53159/00A Abandoned AU5315900A (en) 1999-06-01 2000-06-01 LTiGTstreptococcus pneumoniaeLT/iGT vaccine strain and uses thereof

Country Status (2)

Country Link
AU (1) AU5315900A (en)
WO (1) WO2000072803A2 (en)

Also Published As

Publication number Publication date
WO2000072803A3 (en) 2002-09-12
WO2000072803A2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
WO2002046364A8 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
AU1812001A (en) Cotton transcription factors and their uses
AU6605900A (en) Novel angiopoietin materials and methods
AUPQ155799A0 (en) Therapeutic methods and uses
AU2001252373A1 (en) Strain transducer
AU1285300A (en) Hiv vaccine
AU2002365077A1 (en) Methods and products related to non-viral transfection
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU5977700A (en) Vaccines
AU2534200A (en) Picture-frame
AU1600401A (en) Malaria vaccine
AUPQ233799A0 (en) Recombinant sub-unit vaccine
AU6158700A (en) Vaccine
AU1180800A (en) Yunnan sl-001 strain
AUPR030800A0 (en) Immunomodulatory preparation
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2002249823A1 (en) Acne vaccine
AU2001287269A1 (en) Human genes and expression products
AU5315900A (en) LTiGTstreptococcus pneumoniaeLT/iGT vaccine strain and uses thereof
AU5979300A (en) Angiopoietin-6 and uses thereof
AU5811600A (en) Vaccine
AU4957800A (en) Vaccine against isa virus
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase